» Articles » PMID: 37400246

Presence of Embolic Source and Outcome in Central Retinal Artery Occlusion

Overview
Journal Neurology
Specialty Neurology
Date 2023 Jul 3
PMID 37400246
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The etiology of central retinal artery occlusion (CRAO) is unclear in approximately 50% of patients, suggesting pathomechanical heterogeneity; moreover, little is known about outcomes according to etiology. This study investigated whether the presence of an embolic source affects outcome in CRAO.

Methods: CRAO patients within 7 days of symptom onset were retrospectively enrolled. Clinical parameters, including initial and 1-month visual acuity, CRAO subtype, and brain images, were reviewed. CRAO etiology was categorized as CRAO with or without an embolic source (CRAO-E and CRAO-E). Visual improvement was defined as a decrease in logarithm of the minimum angle of resolution ≥0.3 at 1 month.

Results: A total of 114 patients with CRAO were included. Visual improvement was noted in 40.4% of patients. Embolic sources were identified in 55.3% of patients, and visual improvement group rather than no improvement group was more commonly associated with the presence of an embolic source. In multivariable logistic regression analysis, CRAO-E independently predicted visual improvement (odds ratio 3.00, 95% CI 1.15-7.81, = 0.025).

Discussion: CRAO-E was found to be associated with a better outcome. CRAO-E may be more prone to recanalization than that CRAO-E.

Citing Articles

Clinical characteristics of recurrent non-arteritic retinal artery occlusion.

Kim H, Woo S BMJ Open Ophthalmol. 2024; 9(1).

PMID: 38816011 PMC: 11138310. DOI: 10.1136/bmjophth-2024-001636.


Circulating serum fibroblast growth factor 21 as risk and prognostic biomarker of retinal artery occlusion.

Shi R, Liu H, Xia K, Li Y, Chen T, Li X Sci Rep. 2024; 14(1):11854.

PMID: 38789571 PMC: 11126651. DOI: 10.1038/s41598-024-62588-w.


Central retinal artery occlusion: a stroke of the eye.

Chen C, Singh G, Madike R, Cugati S Eye (Lond). 2024; 38(12):2319-2326.

PMID: 38548943 PMC: 11306586. DOI: 10.1038/s41433-024-03029-w.

References
1.
Libby P, Simon D . Inflammation and thrombosis: the clot thickens. Circulation. 2001; 103(13):1718-20. DOI: 10.1161/01.cir.103.13.1718. View

2.
Ahn S, Woo S, Park K, Jung C, Hong J, Han M . Retinal and choroidal changes and visual outcome in central retinal artery occlusion: an optical coherence tomography study. Am J Ophthalmol. 2015; 159(4):667-76. DOI: 10.1016/j.ajo.2015.01.001. View

3.
Schumacher M, Schmidt D, Jurklies B, Gall C, Wanke I, Schmoor C . Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology. 2010; 117(7):1367-75.e1. DOI: 10.1016/j.ophtha.2010.03.061. View

4.
Lee J, Kim S, Lee S, Kwon O, Kim Y, Byeon S . Co-occurrence of acute retinal artery occlusion and acute ischemic stroke: diffusion-weighted magnetic resonance imaging study. Am J Ophthalmol. 2014; 157(6):1231-8. DOI: 10.1016/j.ajo.2014.01.033. View

5.
Cho K, Ahn S, Cho J, Jung C, Han M, Park S . The Characteristics of Retinal Emboli and its Association With Vascular Reperfusion in Retinal Artery Occlusion. Invest Ophthalmol Vis Sci. 2016; 57(11):4589-98. DOI: 10.1167/iovs.16-19887. View